SEC Comment Letter 0000000000-24-005581 to CorMedix Inc. (CRMD) (CIK 0001410098) (CRMD)
CorMedix Inc. (CRMD) (CIK 0001410098)
Date: May 15, 2024 · CIK: 0001410098 · Accession: 0000000000-24-005581
AI Filing Summary & Sentiment
File numbers found in text: 333-279277
Letter
United States securities and exchange commission logo May 15, 2024 Joseph Todisco Chief Executive Officer CorMedix Inc. 300 Connell Drive, Suite 4200 Berkeley Heights, NJ 07922 Re:CorMedix Inc. Registration Statement on Form S-3 Filed May 9, 2024 File No. 333-279277 Dear Joseph Todisco: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Sean Ewen
Show Raw Text
United States securities and exchange commission logo
May 15, 2024
Joseph Todisco
Chief Executive Officer
CorMedix Inc.
300 Connell Drive, Suite 4200
Berkeley Heights, NJ 07922
Re:CorMedix Inc.
Registration Statement on Form S-3
Filed May 9, 2024
File No. 333-279277
Dear Joseph Todisco:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Sean Ewen